iBio, Inc.
IBIO
$1.04
-$0.03-2.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.72M | -5.16M | -- | -4.36M | -3.99M |
| Total Depreciation and Amortization | 289.00K | 293.00K | -- | 281.00K | 278.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 295.00K | 247.00K | -- | 461.00K | 396.00K |
| Change in Net Operating Assets | -529.00K | 8.00K | -- | -247.00K | -400.00K |
| Cash from Operations | -5.67M | -4.62M | -- | -3.87M | -3.72M |
| Capital Expenditure | -32.00K | -1.00K | -- | -1.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -21.46M | 46.00K | -- | -1.00K | 713.00K |
| Cash from Investing | -21.49M | 45.00K | -- | -2.00K | 713.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -160.00K | -183.00K | -- | -170.00K | -166.00K |
| Issuance of Common Stock | 324.00K | 2.41M | -- | 18.00K | 4.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 46.54M | 5.95M | -- | -- | -- |
| Cash from Financing | 46.71M | 8.18M | -- | -152.00K | -162.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.55M | 3.61M | -- | -4.02M | -3.16M |